Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gary Goldenberg Insider Profile
4 Followers
Gary Goldenberg, CMO at Verrica Pharmaceuticals, holds 94.26K shares in Verrica Pharmaceuticals (Ticker: VRCA).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+58.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gary Goldenberg's holdings
Insider Roles
CMO
Roles that Gary Goldenberg holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 05, 2022 - Jul 05, 2023
Return:+136.80%
The most profitable trade made by Gary Goldenberg
Gary Goldenberg's Trading History
List of latest transactions for each holding click on a transaction to see Gary Goldenberg's performance on stock
You May Also Like
Gary Goldenberg insider profile FAQ
What is the percentage of profitable transactions made by Gary Goldenberg?
The percentage of profitable transactions made by Gary Goldenberg is 67%.
What is the average return per transaction made by Gary Goldenberg?
The average return per transaction made by Gary Goldenberg is 58.90%.
What stocks does Gary Goldenberg hold?
Gary Goldenberg holds: VRCA stocks.
What was Gary Goldenberg’s latest transaction?
Gary Goldenberg latest transaction was an Uninformative Sell of $35.16K.
What was Gary Goldenberg's most profitable transaction?
Gary Goldenberg’s most profitable transaction was an Informative Buy of VRCA stock on July 5, 2022. The return on the trade was 136.80%.
What is Gary Goldenberg's role in Verrica Pharmaceuticals?
Gary Goldenberg's role in Verrica Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.